Top Markets
#1 ADO Protocol ADO Protocol +195.93%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +59.90%
#4 Starpower Starpower +25.13%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +15.10%
#7 Casper Network Casper Network +14.54%
#8 Verus Coin Verus Coin +13.55%
#9 Status Status +12.46%
#10 o1.exchange o1.exchange +10.83%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Kedudukan dalam Saham #33508
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Harga Saham
$1.12
Disegerakkan terakhir: 2026-08-14
Modal Pasaran
$7.52M
Perubahan (1 hari)
4.51%
Perubahan (1 tahun)
-94.79%
Negara
US
Perdagangan NeoImmuneTech, Inc. (950220)

Kategori

Healthcare
Sejarah pecahan saham untuk NeoImmuneTech, Inc. (950220)
Saham NeoImmuneTech, Inc. (simbol: 950220) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 17, 2026.
Satu saham 950220 yang dibeli sebelum Aug 17, 2026 kini bersamaan dengan 0 saham 950220.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE